Lista de obras -

A consensus on criteria for cure of acromegaly.

scientific article published on 21 April 2010

Are women with osteoporosis treated with denosumab at risk of severe COVID-19?

scientific article published on 20 September 2020

Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study

artículo científico publicado en 2008

Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group ⬇️

artículo científico publicado el 1 de enero de 2011

Bone and Joint Disorders in Acromegaly.

artículo científico publicado en 2015

Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update

artículo científico

Clinical review: Growth hormone and cardiovascular risk factors

artículo científico publicado en 2004

Consensus Document on substitution therapy with DHEA in the elderly

artículo científico publicado en 2006

Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men.

artículo científico publicado en 2002

Consensus statement: medical management of acromegaly

artículo científico publicado en 2005

Controversies in Vitamin D: A Statement From the Third International Conference

artículo científico publicado en 2020

Correction to: Pegvisomant in acromegaly: an update.

artículo científico publicado en 2017

Current and Emerging Aspects of Diabetes Mellitus in Acromegaly.

artículo científico publicado en 2016

Current guidelines for adult GH replacement

artículo científico publicado en 2005

Current management practices for acromegaly: an international survey.

artículo científico publicado en 2011

Cushing's syndrome and bone

artículo científico publicado en 2004

Diabetes in Cushing syndrome: basic and clinical aspects ⬇️

artículo científico publicado el 11 de octubre de 2011

Diagnosis and complications of Cushing's syndrome: a consensus statement.

artículo científico publicado en 2003

Does growth hormone play a role in chronic heart failure?

artículo científico publicado en 2002

Drug-induced Osteoporosis: Mechanisms and Clinical Implications ⬇️

artículo científico publicado el 1 de octubre de 2010

Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review.

artículo científico publicado en 2010

Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies.

artículo científico publicado en 2009

Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis

scientific article published on 01 March 2020

Erectile dysfunction and coronary artery disease in patients with diabetes

artículo científico publicado en 2011

Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes

artículo científico publicado en 2016

Expert consensus document: A consensus on the medical treatment of acromegaly

artículo científico publicado en 2014

Fat utilization and arterial hypertension in overweight/obese subjects

artículo científico publicado en 2013

Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG

scientific article (publication date: 31 May 2007)

Glucocorticoid-induced osteoporosis: an update

artículo científico publicado en 2006

Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects

artículo científico publicado en 2007

Glucocorticoids and the regulation of growth hormone secretion ⬇️

artículo científico publicado el 5 de febrero de 2013

Growth hormone deficiency in treated acromegaly and active Cushing's syndrome.

artículo científico publicado en 2017

Growth hormone deficiency in treated acromegaly.

artículo científico publicado en 2014

Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.

artículo científico publicado en 2013

Growth hormone, insulin-like growth factors, and the skeleton

artículo científico publicado en 2008

Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

artículo científico publicado en 2008

HIGH-DOSE AND HIGH-FREQUENCY LANREOTIDE AUTOGEL IN ACROMEGALY: A RANDOMIZED, MULTICENTER STUDY.

artículo científico publicado en 2017

How to improve effectiveness of pegvisomant treatment in acromegalic patients.

artículo científico publicado en 2017

Hyperprolactinemia and bone

scientific article published on 26 March 2020

Hyperprolactinemia and prolactinomas

artículo científico publicado en 2008

Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients

scientific article published on 09 November 2020

Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19

artículo científico publicado en 2020

Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis

artículo científico publicado en 2007

Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?

artículo científico

Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.

artículo científico publicado en 2014

Mechanisms of anabolic therapies for osteoporosis

artículo científico publicado en 2007

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

artículo científico publicado en 2012

Multidisciplinary management of acromegaly: A consensus

artículo científico publicado en 2020

Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects

artículo científico publicado en 2006

Octreotide for acromegaly treatment: a reappraisal

artículo científico publicado en 2013

Parathyroid hormone pulsatility: physiological and clinical aspects

artículo científico publicado en 2015

Pegvisomant in acromegaly: an update

artículo científico publicado en 2017

Pegvisomant in acromegaly: why, when, how.

artículo científico publicado en 2007

Perspectives on glucocorticoid-induced osteoporosis

artículo científico publicado en 2004

Pituitary diseases and bone.

artículo científico publicado en 2014

Points of integration between the intracellular energy sensor AMP-activated protein kinase (AMPK) activity and the somatotroph axis function.

artículo científico

Primary empty sella: Why and when to investigate hypothalamic-pituitary function

artículo científico publicado en 2010

Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era

artículo científico publicado en 2021

SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study

artículo científico publicado en 2015

Should we abandon statins in the prevention of bone fractures?

artículo científico publicado en 2013

The Modern Criteria for Medical Management of Acromegaly.

artículo científico publicado en 2016

The management of the patient with acromegaly and headache: a still open clinical challenge

artículo científico publicado en 2008

The osteo-metabolic phenotype of COVID-19: an update

artículo científico publicado en 2022

The role of patient education in the prevention and management of type 2 diabetes: an overview

artículo científico publicado en 2015

Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index

artículo científico publicado en 2013

Treatment of Cushing disease: overview and recent findings ⬇️

artículo científico publicado el 21 de octubre de 2010

Treatment of glucocorticoid-induced osteoporosis ⬇️

artículo científico publicado el 1 de febrero de 2009

Lista de obras de

A consensus on criteria for cure of acromegaly.

Are women with osteoporosis treated with denosumab at risk of severe COVID-19?

Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study

Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group ⬇️

Bone and Joint Disorders in Acromegaly.

Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update

Clinical review: Growth hormone and cardiovascular risk factors

Consensus Document on substitution therapy with DHEA in the elderly

Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men.

Consensus statement: medical management of acromegaly

Controversies in Vitamin D: A Statement From the Third International Conference

Correction to: Pegvisomant in acromegaly: an update.

Current and Emerging Aspects of Diabetes Mellitus in Acromegaly.

Current guidelines for adult GH replacement

Current management practices for acromegaly: an international survey.

Cushing's syndrome and bone

Diabetes in Cushing syndrome: basic and clinical aspects ⬇️

Diagnosis and complications of Cushing's syndrome: a consensus statement.

Does growth hormone play a role in chronic heart failure?

Drug-induced Osteoporosis: Mechanisms and Clinical Implications ⬇️

Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review.

Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies.

Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis

Erectile dysfunction and coronary artery disease in patients with diabetes

Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes

Expert consensus document: A consensus on the medical treatment of acromegaly

Fat utilization and arterial hypertension in overweight/obese subjects

Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG

Glucocorticoid-induced osteoporosis: an update

Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects

Glucocorticoids and the regulation of growth hormone secretion ⬇️

Growth hormone deficiency in treated acromegaly and active Cushing's syndrome.

Growth hormone deficiency in treated acromegaly.

Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.

Growth hormone, insulin-like growth factors, and the skeleton

Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

HIGH-DOSE AND HIGH-FREQUENCY LANREOTIDE AUTOGEL IN ACROMEGALY: A RANDOMIZED, MULTICENTER STUDY.

How to improve effectiveness of pegvisomant treatment in acromegalic patients.

Hyperprolactinemia and bone

Hyperprolactinemia and prolactinomas

Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients

Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19

Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis

Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?

Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.

Mechanisms of anabolic therapies for osteoporosis

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

Multidisciplinary management of acromegaly: A consensus

Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects

Octreotide for acromegaly treatment: a reappraisal

Parathyroid hormone pulsatility: physiological and clinical aspects

Pegvisomant in acromegaly: an update

Pegvisomant in acromegaly: why, when, how.

Perspectives on glucocorticoid-induced osteoporosis

Pituitary diseases and bone.

Points of integration between the intracellular energy sensor AMP-activated protein kinase (AMPK) activity and the somatotroph axis function.

Primary empty sella: Why and when to investigate hypothalamic-pituitary function

Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era

SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study

Should we abandon statins in the prevention of bone fractures?

The Modern Criteria for Medical Management of Acromegaly.

The management of the patient with acromegaly and headache: a still open clinical challenge

The osteo-metabolic phenotype of COVID-19: an update

The role of patient education in the prevention and management of type 2 diabetes: an overview

Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index

Treatment of Cushing disease: overview and recent findings ⬇️

Treatment of glucocorticoid-induced osteoporosis ⬇️